In in vivo xenograft experiments, MSCs promote the differentiation into CAFs through CXCR4/TGF-β1 signaling in either primary tumor tissues or hepatic metastatic tissues of CRC (68). This evidence concerns the gene CXCR4 and colorectal carcinoma.